7 news items
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
use of or access to this content.
Sources
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
MAIA
6 Jun 24
.
"We remain steadfast in our goals for responsible access to capital. We have increased our access to cash while keeping dilution
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
CORT
HALO
MAIA
6 Jun 24
therapy and immuno-oncology, aiming to significantly improve and extend the lives of those battling cancer. For more information, including access
MAIA Biotechnology Reveals New Clinical Data Showing THIO's Strong Efficacy in Non-Small Cell Lung Cancer
MAIA
4 Jun 24
.
The poster and updated Company presentations can be accessed
MAIA Biotechnology (MAIA) to Showcase Groundbreaking Telomere-Targeting Cancer Treatments at BIO International Convention 2024
AFMD
ALBT
BPTH
4 Jun 24
person’s use of or access to this content.
Sources
o5f 0xkafv8d9q1fti22tfrwnzhwcp5kalo0ao3kt
CRL
IQV
MAIA
31 May 24
not constitute professional and/or financial advice. InvestorBrandMedia.com is not a fiduciary by virtue of any person’s use of or access to this content
6xq8jkg0cbh 77w2hpbgaq1l3m0g39tdpon8558u5f3lk08t
ABBV
JNJ
LLY
21 May 24
professional and/or financial advice. InvestorBrandMedia.com is not a fiduciary by virtue of any person’s use of or access to this content
- Prev
- 1
- Next